Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis

Nitin Dhochak, Kana Ram Jat, Kapil Dev Soni, Yudhyavir Singh, Richa Aggarwal, Rakesh Lodha, Anjan Trikha, Sushil K. Kabra

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Children with cystic fibrosis (CF) constitute a high-risk group for COVID-19 with underlying chronic lung disease. COVID-19 severity varying from mild infection to need of intensive care has been described in children with CF. Two children with significant underlying pulmonary morbidity are described here, who developed severe disease following SARS-CoV-2 infection. Case 1 (a 9-y-old boy) had pneumonia with respiratory failure requiring noninvasive ventilation support. He had delayed clearance of SARS-CoV-2, with recurrence of symptomatic disease with short asymptomatic period in between. He was also diagnosed with CF-related diabetes and allergic bronchopulmonary aspergillosis during the second episode. Case 2 (an 18-mo-old boy) had two episodes of SARS-CoV-2–related severe lower respiratory infection within a period of 2 mo, requiring high-flow nasal oxygen support. Both children had 3rd pulmonary exacerbation but SARS-CoV-2 was not detected in respiratory secretions. To conclude, children with CF with underlying pulmonary morbidity, can develop severe COVID-19 and prolonged SARS-CoV-2 shedding.

Original languageEnglish (US)
Pages (from-to)404-406
Number of pages3
JournalIndian Journal of Pediatrics
Issue number4
StatePublished - Apr 2022

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this